Loading…

FGF23, Frailty, and Falls in SPRINT

BACKGROUND/OBJECTIVES Chronic kidney disease (CKD) is associated with frailty. Fibroblast growth factor 23 (FGF23) is elevated in CKD and associated with frailty among non‐CKD older adults and individuals with human immunodeficiency virus. Whether FGF23 is associated with frailty and falls in CKD is...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Geriatrics Society (JAGS) 2021-02, Vol.69 (2), p.467-473
Main Authors: Jovanovich, Anna, Ginsberg, Charles, You, Zhiying, Katz, Ronit, Ambrosius, Walter T., Berlowitz, Dan, Cheung, Alfred K., Cho, Monique, Lee, Alexandra K., Punzi, Henry, Rehman, Shakaib, Roumie, Christianne, Supiano, Mark A., Wright, Clinton B., Shlipak, Michael, Ix, Joachim H., Chonchol, Michel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND/OBJECTIVES Chronic kidney disease (CKD) is associated with frailty. Fibroblast growth factor 23 (FGF23) is elevated in CKD and associated with frailty among non‐CKD older adults and individuals with human immunodeficiency virus. Whether FGF23 is associated with frailty and falls in CKD is unknown. DESIGN Cross‐sectional and longitudinal observational study. SETTING Systolic Blood Pressure Intervention Trial (SPRINT), a randomized trial evaluating standard (systolic blood pressure [SBP]
ISSN:0002-8614
1532-5415
DOI:10.1111/jgs.16895